The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
High-dose oral N -acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Abstract
Neutrophilic airway inflammation is a hallmark of cystic fibrosis (CF). As high oxidant producers, airway neutrophils contribute largely to the systemic redox imbalance seen in CF. In turn, this chronic and profound imbalance can impact circulating neutrophils before their migration into airways. Indeed, in 18 CF patients with stable disease, blood neutrophils were readily deficient in the pivotal antioxidant glutathione ( P = 0.003, compared with 9 healthy controls). In a phase 1 study, this deficiency was improved ( P = 0.025) by the glutathione prodrug N -acetylcysteine, given orally in high doses (0.6 to 1.0 g three times daily, for 4 weeks). This treatment was safe and markedly decreased sputum elastase activity ( P = 0.006), the strongest predictor of CF pulmonary function. Consistently, neutrophil burden in CF airways was decreased upon treatment ( P = 0.003), as was the number of airway neutrophils actively releasing elastase-rich granules ( P = 0.005), as measured by flow cytometry. Pulmonary function measures were not improved, as expected with short-term treatment. After excluding data from subjects without baseline airway inflammation, positive treatment effects were more pronounced and included decreased sputum IL-8 levels ( P = 0.032). Thus, high-dose oral N -acetylcysteine has the potential to counter the intertwined redox and inflammatory imbalances in CF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Seventeen-colour flow cytometry: unravelling the immune system
Perfetto, S. P., Chattopadhyay, P. K., & Roederer, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1416 · Cited by 1,019
Gene expression and the thiol redox state
Arrigo, A.-P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00175-6 · Cited by 510
A practical approach to multicolor flow cytometry for immunophenotyping
Baumgarth, N., & Roederer, M. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00229-5 · Cited by 449
Clinical applications of N-acetylcysteine.
Kelly, G. S. (1998) · PubMed · Cited by 419
Systemic deficiency of glutathione in cystic fibrosis
Roum, J. H., Buhl, R., McElvaney, N. G., Borok, Z., & Crystal, R. G. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.6.2419 · Cited by 399
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13572 · Cited by 373
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
MUHLEBACH, M. S., STEWART, P. W., LEIGH, M. W., & NOAH, T. L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9808096 · Cited by 354
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213572 · Cited by 327
Mechanisms of Leukocyte Sequestration in Inflamed Lungs
DOERSCHUK, C. M. (2001) · Microcirculation · doi:10.1111/j.1549-8719.2001.tb00159.x · Cited by 277
Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
Inflammation and Infection in Naive Human Cystic Fibrosis Airway Grafts
Tirouvanziam, R., de Bentzmann, S., Hubeau, C., Hinnrasky, J., Jacquot, J., Péault, B., & Puchelle, E. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.2.4214 · Cited by 235
Self-citationReduction in Viscosity of Cystic Fibrosis Sputum in Vitro by Gelsolin
Vasconcellos, C. A., Allen, P. G., Wohl, M. E., Drazen, J. M., Janmey, P. A., & Stossel, T. P. (1994) · Science · doi:10.1126/science.8310295 · Cited by 213
Neutrophil Priming in Host Defense: Role of Oxidants as Priming Agents
Swain, S. D., Rohn, T. T., & Quinn, M. T. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602753625870 · Cited by 181
Cystic fibrosis lung inflammation: early, sustained, and severe.
Cantin, A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697269 · Cited by 181
New approaches to fluorescence compensation and visualization of FACS data
Tung, J. W., Parks, D. R., Moore, W., Herzenberg, L. A., & Herzenberg, L. A. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.11.016 · Cited by 170
Self-citationHudson, V. M. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00530-5 · Cited by 166
Pulmonary oxidative stress response in young children with cystic fibrosis
Hull, J., Vervaart, P., Grimwood, K., & Phelan, P. D. (1997) · Thorax · doi:10.1136/thx.52.6.557 · Cited by 139
Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis
Sagel, S. D., Sontag, M. K., Wagener, J. S., Kapsner, R. K., Osberg, I. M., & Accurso, F. J. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.129847 · Cited by 137
Woolhouse, I., Bayley, D. L., & Stockley, R. A. (2002) · Thorax · doi:10.1136/thorax.57.8.667 · Cited by 130
Increased DNA Levels in Bronchoalveolar Lavage Fluid Obtained From Infants With Cystic Fibrosis
Kirchner, K., Wagener, J. S., Khan, T. Z., Copenhaver, S. C., & Accurso, F. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912759 · Cited by 128
SEELY, A. J. E., L., J. L. P., & Christou, N. V. (2003) · Critical Care · doi:10.1186/cc1853 · Cited by 112
Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors
Wood, L. G., Fitzgerald, D. A., Gibson, P. G., Cooper, D. M., Collins, C. E., & Garg, M. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719028 · Cited by 111
Primary inflammation in human cystic fibrosis small airways
Tirouvanziam, R. M., Khazaal, I., & Péault, B. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00419.2001 · Cited by 97
Self-citationZahler, S., Kowalski, C., Brosig, A. M., Kupatt, C., Becker, B. F., & Gerlach, E. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00206-2 · Cited by 86
Glutathione Protects Mice from Lethal Sepsis by Limiting Inflammation and Potentiating Host Defense
Villa, P., Saccani, A., Sica, A., & Ghezzi, P. (2002) · The Journal of Infectious Diseases · doi:10.1086/340042 · Cited by 86
Oxidant-Antioxidant Balance in Granulocytes During ARDS
Laurent, T., Markert, M., Feihl, F., Schaller, M., & Perret, C. H. (1996) · CHEST Journal · doi:10.1378/chest.109.1.163 · Cited by 85
Konstan, M. W., & Davis, P. B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00146-1 · Cited by 76
Behr, J., Degenkolb, B., Krombach, F., & Vogelmeier, C. F. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00204902 · Cited by 71
Santangelo, F. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456567 · Cited by 70
Davis, P. B. (2001) · Pediatrics in Review · doi:10.1542/pir.22-8-257 · Cited by 63
Potential for antioxidant therapy of cystic fibrosis
Cantin, A. (2004) · Current opinion in pulmonary medicine · doi:10.1097/01.mcp.0000138997.29276.a1 · Cited by 51
Mårtensson, J., Gustafsson, J., & Larsson, A. (1988) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800713 · Cited by 44
Kemeny, D. M., & Peakman, M. (1998) · BMJ · doi:10.1136/bmj.316.7131.600 · Cited by 2
Cited by
Glutathione dysregulation and the etiology and progression of human diseases
Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., & Hammond, C. L. (2009) · bchm · doi:10.1515/bc.2009.033 · Cited by 1,114
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721
Self-citationRushworth, G. F., & Megson, I. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.006 · Cited by 719
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
Liu, R.-M., & Desai, L. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.009 · Cited by 702
Metadata
- Authors
- Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-03-13
- Volume
- 103
- Issue
- 12
- Pages
- 4628-4633
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967713626
- Cited by
- 253
- References
- 35
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.